Harvard Bioscience Inc (HBIO):企業の財務・戦略的SWOT分析

◆英語タイトル:Harvard Bioscience Inc (HBIO) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME58380FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥50,625見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Harvard Bioscience Inc (HBIO) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Harvard Bioscience Inc (Harvard Bioscience) develops, manufactures and markets instruments, consumables, systems and software. The company’s products include spectrophotometers, plate readers, gel electrophoresis equipment, amino acid analyzers, electroporation and electrofusion instruments, wireless monitors, data acquisition and analysis products and software, and syringe pump and peristaltic pumps, among others. It also provides data analysis, training and installation services. Harvard Bioscience serves research scientists at pharmaceutical and biotechnology companies, hospitals, universities, government laboratories, and contract research organizations. The company markets products directly in the US, the UK, Germany, France, Sweden, Canada, Italy, Spain and China; and also through a network of distributors in other countries. Harvard Bioscience is headquartered in Holliston, Massachusetts, the US.

Harvard Bioscience Inc Key Recent Developments

Feb 18,2021: Harvard Bioscience Schedules Fourth Quarter 2020 Earnings Conference Call for March 10, 2021 at 8:00 AM ET
Dec 22,2020: Harvard Bioscience announces new credit facility
Nov 05,2020: Harvard Bioscience announces third quarter 2020 financial results
Aug 05,2020: Harvard Bioscience announces second quarter 2020 financial results
Jul 20,2020: Harvard Bioscience Schedules Second Quarter 2020 Earnings Conference Call for August 5, 2020 at 8:00 AM ET

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Harvard Bioscience Inc – Key Facts
Harvard Bioscience Inc – Key Employees
Harvard Bioscience Inc – Key Employee Biographies
Harvard Bioscience Inc – Major Products and Services
Harvard Bioscience Inc – History
Harvard Bioscience Inc – Company Statement
Harvard Bioscience Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Harvard Bioscience Inc – Business Description
Geographical Segment: Asia
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Rest of World
Performance
Geographical Segment: United States
Performance
R&D Overview
Harvard Bioscience Inc – Corporate Strategy
Harvard Bioscience Inc – SWOT Analysis
SWOT Analysis – Overview
Harvard Bioscience Inc – Strengths
Harvard Bioscience Inc – Weaknesses
Harvard Bioscience Inc – Opportunities
Harvard Bioscience Inc – Threats
Harvard Bioscience Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Harvard Bioscience Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Harvard Bioscience Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Harvard Bioscience Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 18, 2021: Harvard Bioscience Schedules Fourth Quarter 2020 Earnings Conference Call for March 10, 2021 at 8:00 AM ET
Dec 22, 2020: Harvard Bioscience announces new credit facility
Nov 05, 2020: Harvard Bioscience announces third quarter 2020 financial results
Aug 05, 2020: Harvard Bioscience announces second quarter 2020 financial results
Jul 20, 2020: Harvard Bioscience Schedules Second Quarter 2020 Earnings Conference Call for August 5, 2020 at 8:00 AM ET
May 05, 2020: Harvard Bioscience announces first quarter 2020 financial results
Apr 18, 2020: HARVARD BIOSCIENCE receives loan under Paycheck Protection Program
Apr 06, 2020: Harvard Bioscience announces appointment of Susan Steele to board of directors
Feb 26, 2020: Harvard Bioscience announces fourth quarter 2019 financial results
Feb 11, 2020: Harvard Bioscience Schedules Fourth Quarter 2019 Earnings Conference Call for February 26, 2020 at 8:00 AM ET
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Harvard Bioscience Inc, Key Facts
Harvard Bioscience Inc, Key Employees
Harvard Bioscience Inc, Key Employee Biographies
Harvard Bioscience Inc, Major Products and Services
Harvard Bioscience Inc, History
Harvard Bioscience Inc, Subsidiaries
Harvard Bioscience Inc, Key Competitors
Harvard Bioscience Inc, Ratios based on current share price
Harvard Bioscience Inc, Annual Ratios
Harvard Bioscience Inc, Annual Ratios (Cont...1)
Harvard Bioscience Inc, Annual Ratios (Cont...2)
Harvard Bioscience Inc, Interim Ratios
Harvard Bioscience Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Harvard Bioscience Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Harvard Bioscience Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Harvard Bioscience Inc (HBIO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • TMX Group Ltd (X):企業の財務・戦略的SWOT分析
    TMX Group Ltd (X) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • EDF Renewable Energy Inc-エネルギー分野:企業M&A・提携分析
    Summary EDF Renewable Energy, Inc. (EDF Renewable Energy), formerly, enXco, Inc., is an integrated energy company. The company designs, develops, constructs and operates renewable energy projects in the biogas, biomass, hydro, solar, wind and marine energy sectors; and provides storage solutions. It …
  • Barkan Wine Cellars Ltd:企業の戦略的SWOT分析
    Barkan Wine Cellars Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Fuji Seal International Inc.:企業の戦略・SWOT・財務情報
    Fuji Seal International Inc. - Strategy, SWOT and Corporate Finance Report Summary Fuji Seal International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Actinogen Medical Ltd (ACW)-製薬・医療分野:企業M&A・提携分析
    Summary Actinogen Medical Ltd (Actinogen), formerly Actinogen Ltd is a biotechnology company that undertakes research in Alzheimer’s disease and other chronic neurodegenerative diseases. The company’s xanamem is a novel drug under development for the treatment of Alzheimer's disease. It develops dru …
  • Avacta Group Plc (AVCT):製品パイプライン分析
    Summary Avacta Group Plc (Avacta) is a developer therapeutic molecules used in a wide range of life sciences applications in research and diagnostics. The company offers products which include optim and sensipod. It also develops UCB celltech, which is an analytical instrument. Avacta’s sensipod is …
  • Medicom Innovation Partner as-医療機器分野:企業M&A・提携分析
    Summary Medicom Innovation Partner a/s (Medicom), formerly Bang & Olufsen Medicom, a subsidiary of Phillips-Medisize Corp, is a medical device company that develops electronic-based drug delivery and connected health systems. The company offers services such as device strategy and direction, device …
  • Globus Medical Inc (GMED):企業の財務・戦略的SWOT分析
    Globus Medical Inc (GMED) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • ElectraNet Pty Ltd:企業の戦略的SWOT分析
    ElectraNet Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Kazakhtelecom (KZTK):企業の財務・戦略的SWOT分析
    Kazakhtelecom (KZTK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • RXi Pharmaceuticals Corporation:企業のM&A・事業提携・投資動向
    RXi Pharmaceuticals Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's RXi Pharmaceuticals Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • TOA OIL Co Ltd (5008):企業の財務・戦略的SWOT分析
    Summary TOA OIL Co Ltd (TOA OIL), a subsidiary of Showa Shell Sekiyu KK is an oil and gas company that offers contract refining of crude oil. The company offers products such as diesel oil, coker naphtha scrubber, kerosene, polynaphtha units, LPG hydrofining unit, gasoline scrubber, and vacuum diese …
  • Bloomberg LP:企業の戦略的SWOT分析
    Bloomberg LP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Factor Therapeutics Ltd (FTT):医療機器:M&Aディール及び事業提携情報
    Summary Factor Therapeutics Ltd (FTL), formerly Tissue Therapies Ltd, is a developer of wound care therapeutics. The company develops treatments for acute and chronic wound healing applications such as chronic skin ulcers and burns. Its lead therapeutic candidate, VF-001 is a targeted growth factor …
  • Advanced Accelerator Applications SA (AAAP)-医療機器分野:企業M&A・提携分析
    Summary Advanced Accelerator Applications SA (AAA) is a healthcare products provider that offers molecular nuclear medicine and diagnostic and therapeutic products. The company’s lead product candidate comprises Lutathera, a lutetium-177 somatostatin analogue peptide that is used for the treatment o …
  • Juniper Networks Inc (JNPR):企業の財務・戦略的SWOT分析
    Juniper Networks Inc (JNPR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • LM Wind Power Holding AS:企業の戦略的SWOT分析
    LM Wind Power Holding AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Cisco Systems, Inc (CSCO)-石油・ガス分野:企業M&A・提携分析
    Summary Cisco Systems, Inc (Cisco) is a technology services provider, which designs, manufactures and sells Internet protocol (IP)-based networking systems and other products. The company’s products include blade switches, analytics and automation software, application networking services, interface …
  • Penta-Ocean Construction Co Ltd:企業の戦略・SWOT・財務分析
    Penta-Ocean Construction Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Penta-Ocean Construction Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Sinphar Pharmaceutical Co Ltd (1734):企業の財務・戦略的SWOT分析
    Sinphar Pharmaceutical Co Ltd (1734) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆